0
Abstract: Poster Presentations |

Perceived Locus of Symptom Limitation during Constant Work Rate Cycle Ergometry in COPD Patients Treated with Tiotropium FREE TO VIEW

Denis E. O’Donnell, MD*; Francois Maltais, MD; Peter Frith, MD; Anne Marie Southcott, MD; Steven Kesten, MD, FCCP; Alan Hamilton, PhD
Author and Funding Information

Queens University, Kingston, ON, Canada


Chest


Chest. 2004;126(4_MeetingAbstracts):838S. doi:10.1378/chest.126.4_MeetingAbstracts.838S-a
Text Size: A A A
Published online

Abstract

PURPOSE:  Both breathing discomfort and leg discomfort contribute to perceived symptom limitation in many COPD patients during incremental cycle ergometry (IE); perceived symptom limitation during constant work rate cycle ergometry (CWRE) has not been evaluated. In a double-blind, placebo-controlled study evaluating the effects of tiotropium on exercise tolerance in patients with COPD, we compared perceived symptom limitation during IE and CWRE, and evaluated the effects of tiotropium on perceived symptom limitation during CWRE.

METHODS:  248 COPD patients performed IE and CWRE at screening, and CWRE after 6 weeks of treatment. Patients rated breathing discomfort and leg discomfort (Borg scale) at the point of symptom limitation and reported the perceived symptom limitation using a simple questionnaire (Hamilton et al CHEST 1996;110:1255).

RESULTS:  The tableScreeningDay 42 CWREIECWRETiotropiumPlaceboNumber of patients248248131117BD50.8%40.3%27.5%*41.9%BD / LD33.1%43.5%41.2%38.5%LD16.1%14.5%29.8%*18.0%None0%1.6%1.5%1.7%*

p<0.01 vs. placebo, Chi-square test

below shows the percentage of patients who perceived symptom limitation as breathing discomfort alone (BD), a combination of breathing and leg discomfort (BD / LD), leg discomfort alone (LD), neither breathing nor leg discomfort (None). There was a significant shift in perceived symptom limitation following treatment with tiotropium, with a reduction in the proportion of patients with BD alone as the perceived symptom limitation and an increase in the proportion of patients with LD alone as the perceived symptom limitation (p<0.01). At the point of symptom limitation, breathing discomfort was greater than leg discomfort at baseline (adjusted mean: 7 vs. 6.3 Borg units) and with placebo (7 vs. 6.5 Borg units), but breathing discomfort was less than leg discomfort with tiotropium (6.3 vs. 6.5 Borg units).

CONCLUSION:  As a result of tiotropium-induced reductions in exertional dyspnea, patients are more likely to report that leg discomfort contributes to symptom limitation during exercise.

CLINICAL IMPLICATIONS:  In the assessment of disability in patients with COPD, consideration should be given to the relative role of breathing discomfort and leg discomfort to symptom limitation.

DISCLOSURE:  D.E. O’Donnell, Boehringer Ingelheim and Pfizer

Wednesday, October 27, 2004

12:30 PM- 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543